Related Experiment Video
Updated: Jan 4, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
Mutant p53 antagonizes p63/p73-mediated tumor suppression via Notch1
Jin Zhang1, Wenqiang Sun2, Xiangmudong Kong2
1Comparative Oncology Laboratory, Schools of Veterinary Medicine and Medicine, University of California, Davis, CA 95616; jinzhang@ucdavis.edu xbchen@ucdavis.edu.
Abstract:
p53 is the most frequently mutated gene in human cancers and mutant p53 has a gain of function (GOF) that promotes tumor progression and therapeutic resistance. One of the major GOF activities of mutant p53 is to suppress 2 other p53 family proteins, p63 and p73. However, the molecular basis is not fully understood. Here, we examined whether mutant p53 antagonizes p63/p73-mediated tumor suppression in vivo by using mutant p53-R270H knockin and TAp63/p73-deficient mouse models. We found that knockin mutant p53-R270H shortened the life span of p73 mice and subjected TAp63 or p73 mice to T lymphoblastic lymphomas (TLBLs). To unravel the underlying mechanism, we showed that mutant p53 formed a complex with Notch1 intracellular domain (NICD) and antagonized p63/p73-mediated repression of HES1 and ECM1. As a result, HES1 and ECM1 were overexpressed in TAp63 ;p53 and p73 ;p53 TLBLs, suggesting that normal function of HES1 and ECM1 in T cell activation is hyperactivated, leading to lymphomagenesis. Together, our data reveal a previously unappreciated mechanism by which GOF mutant p53 hijacks the p63/p73-regulated transcriptional program via the Notch1 pathway.
Insights
Gain-of-function mutant p53 (mutant p53) promotes cancer by suppressing p63 and p73. This study reveals mutant p53 hijacks the Notch1 pathway to overexpress HES1 and ECM1, driving T lymphoblastic lymphomas.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The tumor suppressor p53 is frequently mutated in human cancers, with mutant p53 exhibiting gain-of-function (GOF) activities that promote tumor progression and therapeutic resistance.
- A key GOF activity of mutant p53 is the suppression of p63 and p73, but the underlying molecular mechanisms remain incompletely understood.
Purpose of the Study:
- To investigate the in vivo mechanism by which mutant p53 antagonizes p63/p73-mediated tumor suppression.
- To elucidate the role of the Notch1 pathway in mutant p53-driven lymphomagenesis.
Main Methods:
- Utilized mutant p53-R270H knockin mouse models and TAp63/p73-deficient mice.
- Examined protein-protein interactions between mutant p53, Notch1 intracellular domain (NICD), p63, and p73.
- Analyzed the expression of HES1 and ECM1 in relevant mouse models and lymphomas.
Main Results:
- Mutant p53-R270H expression shortened the lifespan of p73-deficient mice and induced T lymphoblastic lymphomas (TLBLs) in TAp63 or p73-deficient mice.
- Mutant p53 formed a complex with NICD, thereby antagonizing p63/p73-mediated repression of HES1 and ECM1.
- Overexpression of HES1 and ECM1 was observed in TAp63;p53 and p73;p53 TLBLs, indicating hyperactivation of their normal functions in T cell activation.
Conclusions:
- Gain-of-function mutant p53 utilizes the Notch1 pathway to suppress p63/p73 tumor suppressor functions.
- This hijacking leads to the overexpression of HES1 and ECM1, ultimately promoting lymphomagenesis.
- The findings reveal a novel mechanism of oncogenesis driven by GOF mutant p53 through the p63/p73 and Notch1 pathways.
Related Concept Videos
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

